Immune checkpoint inhibitor
Immune checkpoint inhibitor | |
---|---|
Term | Immune checkpoint inhibitor |
Short definition | immune checkpoint inhibitor (ih-MYOON CHEK-poynt in-HIH-bih-ter) A type of drug that blocks proteins called checkpoints produced by some types of cells in the immune system, such as B. T-cells, and some cancer cells are formed. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
immune checkpoint inhibitor - (pronounced) (ih-MYOON CHEK-poynt in-HIH-bih-ter) A type of drug that blocks proteins called checkpoints produced by some types of cells in the immune system, such as B. T-cells, and some cancer cells are formed. These checkpoints help keep the immune response from getting too strong and can sometimes stop T cells from killing cancer cells. When these checkpoints are blocked, T cells are better able to kill cancer cells. Examples of checkpoint proteins found on T cells or cancer cells are PD-1/PD-L1 and CTLA-4/B7-1/B7-2. Some immune checkpoint inhibitors are used to treat cancer
External links
- Medical encyclopedia article on Immune checkpoint inhibitor
- Wikipedia's article - Immune checkpoint inhibitor
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski